i&i Biotech Fund (i&i Bio) is a Luxembourg-based venture capital fund focused on innovative European life science companies in drug discovery, medtech, diagnostics, and AI. Established in 2021 in cooperation with the European Investment Fund (EIF) and i&i Prague, it manages over €53M and invests in early-stage biotech ventures.
33% of their portfolio is in Biotech & Life Sciences.
Portfolio
6
Fund Size
$57M
Top Stage
Series A
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
6 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| HHeartBeat.bio | Seed | — | Nov 2023 |
 iQure | Unknown | $1.2M | Jan 2023 |
| EEnzyre | Series A | — | Nov 2022 |
 Nanoligent | Series A | — | — |
 Theorema | Pre-Seed | — | — |
| CCeleris | Seed | $4.4M | — |
Top Co-Investors
Oost NL1 shared
Takeda Ventures, Inc.1 shared
Angel Invest1 shared
Exor Ventures1 shared
Inveready1 shared
Banco Sabadell1 shared
Kaya VC1 shared
Credo Ventures1 shared
Amino Collective1 shared
Keiretsu Forum1 shared
APEX Ventures1 shared
Amadeus APEX Technology Fund1 shared
Last updated: 8 September 2026